 development antibodies patient subcutaneous recombinant natural Systemic administration humans antibodies specific case patient metastatic rectal carcinoma long-term subcutaneous combination subcutaneous interferon-alpha IFN-alpha patient antibodies recombinant natural cytokine Detectable serum levels antibodies inhibition immune responsiveness vivo